Tilray’s stock price has tumbled some 24% since the start of the week as its Q3 2025 financial figures failed
Organigram has reported a 25% year-on-year increase in revenues over its third quarter as sales in its home market rebounded.
Bright Green, one of the few companies eligible for authorisation to grow, manufacture and sell cannabis under both Federal and
On this episode of BofC Live, we connect with Paolo De Luca, the Chief Strategy Officer of Moncton, New Brunswick-based
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
